Innovation Partners
A massive thank you to the companies and organizations that brings together our community of innovators shaping the future of the clinical trial industry.
Our Presenting Sponsor:
YPrime streamlines the clinical trial journey with a configurable platform designed for speed, quality, and certainty. With 50% faster IRT startup times, up to 30% faster eCOA launch times, and quality standards 50% above the industry average. YPrime helps solve for certainty.
Why we’re excited about partnering with YPrime:
YPrime has been a leader in clinical research technologies, including expertise in eCOA, IRT, eConsent, and patient engagement. Cofounder Shawn Blackburn and the YPrime team played a foundational role in forming the Innovation Network and serve as a critical thought partner and the presenting sponsor.
ACRO advocates as the collective voice of innovative clinical research and technology organizations to regulators and policymakers, educating stakeholders and advocating for policies that foster efficient, effective and safe conduct of clinical research.
Why we’re excited about partnering with ACRO
The Innovation Network aims to add value to participants beyond business development. The network values commerce and wants participants to be successful. At the same time, we want the Gathering to be focused on genuine thought leadership. ACRO is focused squarely on improving future of clinical research; the mission overlap with the Innovation Network could scarcely be more fitting.
Lokavant was born within Biopharma to improve clinical trial performance by providing study teams with a Clinical Trial Intelligence Platform that delivers real-time, AI-driven data insights to enable researchers to design, plan, and execute trials more efficiently while boosting their confidence in making well-informed decisions.
Why we’re excited about partnering with Lokavant
The Innovation Network has identified 1) trial timelines and 2) real applications of AI as key areas of needed thought leadership. Lokovant works and leads at the intersection of both.
Through focused insights and execution, Endo develops and delivers life-enhancing therapies. Endo’s team members collaborate to bring forward pharmaceutical solutions that make a real difference for customers and patients.
Why we’re excited about partnering with ENDO
Endo has already impacted the development of the Innovation Network. Their insights in how biopharma can better consider and support site interactions has already shown real leadership. Working together on the Gathering is a manifestation of how we all hope the Innovation Network will develop. The participants shape the network, as they work to shape the sector.
Diligent Pharma is redefining vendor qualification and management within the clinical trial landscape through its tech-enabled, centralized quality and risk management platform. By integrating regulatory compliance expertise with a secure technology solution, Diligent provides a one-stop resource for managing vendor discovery, risk assessment, selection, and oversight activities.
The Diligent platform, firmly rooted in the ICH Vendor Risk Management Framework, houses qualification packages and risk assessments for hundreds of vendors across 32 clinical trial service categories. Global regulatory authorities accept Diligent's centralized model as a valid approach to vendor qualification and oversight, allowing sponsors to save significant time by eliminating redundant steps through a system that ensures compliance and supports smarter, data-informed decision-making.
Why we’re excited about partnering with Diligent Pharma
The Innovation Network values partnerships that drive efficiency and quality in clinical research, and Diligent Pharma exemplifies this commitment. Their centralized platform simplifies vendor management while enhancing trial quality and compliance. Not only does Diligent’s approach align with our core vision and mission, Diligent supports the charge of the broader industry to compress clinical trial start-up times and facilitate getting treatments to patients more quickly.
MRN accelerates patient recruitment and improves patient engagement and retention through site-centric and patient-centric solutions. Our in-home trial delivery, global site network and digital solutions bring trials to the patient’s own community, creating more flexible, diverse and accessible trials, making participation easier for patients and engaging more sites around the world.
Why we’re excited about partnering with MRN
MRN shares a common mission with so many members of the Innovation Network: advancing patient-centric solutions and reducing site burden in clinical trials.From building a site network to in-home trial delivery, MRN works to be where patients are. These matters are near and near to our hearts -- from Main Stage Talks, Dive Teams, and published work on the topics, to helping to launch a site-centric conference. We're excited what MRN can add to the marketplace of ideas
Clinigen Clinical Supplies Management combines market-leading clinical trial supplies such as packaging and labelling, global storage and distribution, comparator sourcing, as well as biological sample management services such as sample storage.
Part of Clinigen’s global supply chain facility and depot network, Clinigen Clinical Supplies Management delivers tailored solutions for clients to ensure their clinical trials are a success, regardless of the size, scope, or stage of the projects.
They provide their clients access to 25+ years of clinical supply expertise and industry best cycle times.
Why we’re excited about partnering with Clinigen
Clinigen can help the community get a fuller picture. As we aim to lift our eyes to global impact, Clinigen has had eyes there for years. From pharmacovigilence to supply management to regulatory affairs, the expertise of the Clinigen team broadens and strengthens the network's understanding. And we value the mission alignment: Clinigen works as pathfinders in patient-centric clinical solutions, and we can applaud the mission to work towards a world with "no patient left behind by unnecessary delays."
Flint is a next-generation Clinical Trial Management System (CTMS) designed by sites, for sites. By centralizing and streamlining study management, Flint empowers sites to minimize deviations and collect 100% of their negotiated revenue, all with minimal administrative overhead. By focusing on operational efficiency, Flint enables sites to focus more on patient care and trial execution.
The Playbook partners with eClinical startup companies planning to transition from a founder led customer discovery sales approach to a scalable sales capability that will generate consistent growth. We help startups form a strong commercial foundation from which to confidently deploy their resources and capital.